What question did this study set out to answer?

To summarize the pathophysiological mechanisms, clinical manifestations, and prognostic impact of cardiovascular disease across stages of chronic kidney disease.

March 15, 2021CirculationOpen Access

Cardiovascular Disease in Chronic Kidney Disease

View Full Paper

Ask AI

Bookmark

Why the study?

Patients with chronic kidney disease exhibit an elevated cardiovascular risk and complex pathophysiological remodeling, warranting a summary of current understanding and clinical consequences.

Population

Patients with chronic kidney disease

Design

Overview article

Authors

JJJoachim JankowskiCross-Cutting Cardiology JFJürgen FloegeDélégation Paris 5 DFDanilo FliserPreventive Cardiology

Discussion

Member takes

Implication

Highlights urgent CV risk mitigation in CKD; leaves open targeted therapies against accelerated aging.

Key Points

To summarize the pathophysiological mechanisms, clinical manifestations, and prognostic impact of cardiovascular disease across stages of chronic kidney disease.
Reviewed clinical and epidemiological evidence assessing cardiovascular event risk across early (stages 1–3) and advanced (stages 4–5) chronic kidney disease.
Synthesized molecular and cellular mechanisms of chronic inflammation-induced vascular and myocardial remodeling.
Cardiovascular disease is the leading cause of mortality in patients with chronic kidney disease, exceeding progression to end-stage renal disease.
Cardiovascular event rates increase progressively from early-stage disease (stages 1–3) to advanced disease (stages 4–5), manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac death.
Chronic systemic inflammation drives accelerated cardiovascular aging characterized by vascular calcification, vascular senescence, cardiac valve calcification, and myocardial fibrosis.

Structured PICO

Population

Patients with chronic kidney disease (CKD)

CKD induces a systemic proinflammatory state that accelerates cardiovascular aging, making cardiovascular events the leading cause of death in these patients.

Cite This Study

Jankowski et al. (2021) studied this question.

synapsesocial.com/papers/69bec4119d78ff1f74fe4a03 https://doi.org/10.1161/circulationaha.120.050686

Topics

Women and heart disease COVID-19 cardiovascular Cardiovascular prevention

View Full Paper

Ask AI

Bookmark

Cardiovascular Disease in Chronic Kidney Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Topics

Cardiovascular Disease in Chronic Kidney Disease

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider